Results 101 to 110 of about 4,127 (170)

Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies? [PDF]

World J Hepatol, 2023
Elvevi A, Laffusa A, Elisei F, Morzenti S, Guerra L, Rovere A, Invernizzi P, Massironi S.   +7 more
europepmc   +1 more source

Safety and Efficacy of External Beam Radiation Therapy in Hepatocellular Carcinoma Patients Previously Treated With Yttrium 90 Transarterial Radioembolization. [PDF]

Adv Radiat Oncol
Thonglert K, Tsai J, Monsky WL, Anderson AC, Grassberger C, Bowen SR, Nyflot MJ, He Y, Zaki P, Johnson GE, Apisarnthanarax S.   +10 more
europepmc   +1 more source

Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series. [PDF]

Cancers (Basel), 2023
Vermeulen S, De Keukeleire K, Dorny N, Colle I, Van Den Bossche B, Nuttens V, Ooms D, De Bondt P, De Winter O.   +8 more
europepmc   +1 more source

Hepatic Artery Infusion Chemotherapy Compared to Transarterial Radioembolization For Unresectable Colorectal Liver Metastases. [PDF]

Ann Surg
Saadat LV, Chou J, Gonen M, Lee RM, Maithel SK, Li A, Poultsides GA, Aiken TJ, Schwartz PB, Meram E, Abbott DE, Robbins KJ, Fields RC, Paranjpe A, Datta J, Connell LC, Saltz L, Cercek A, Kemeny N, Sze DY, Yarmohammadi H, Sofocleous CT, Jarnagin W, D'Angelica M.   +23 more
europepmc   +1 more source

Voxel-based dosimetry for predicting treatment response to transarterial radioembolization in hepatocellular carcinoma: significance of intratumoral dose distribution. [PDF]

EJNMMI Phys
Suh M, Kim KM, Choi JW, Lee JS, Paeng JC, Kim HC.   +5 more
europepmc   +1 more source

Price Analysis of Systemic Therapies and Transarterial Radioembolization for Treatment of Unresectable Hepatocellular Carcinoma. [PDF]

J Mark Access Health Policy
Williams AO, Anderson N, Gwon YG, Wifler W.   +3 more
europepmc   +1 more source

Assessment of Preprocedural Factors Associated with 5-Year Complete Response After Transarterial Radioembolization in Patients with Hepatocellular Carcinoma. [PDF]

Diagnostics (Basel)
Park J, Kim DK, Lee S, Hwang SH.
europepmc   +1 more source

Post-Treatment PET/CT Dosimetry to Predict Contralateral Lobe Hypertrophy After Transarterial Radioembolization for Hepatocellular Carcinoma. [PDF]

Korean J Radiol
Kang YK, Suh M, Choi JW, Kim HC, Paeng JC.   +4 more
europepmc   +1 more source

Q.Liver software for the planning of treatment of liver cancer via transarterial radioembolization with yttrium-90 resin microspheres based on single-photon emission computed tomography-computed tomography. [PDF]

Quant Imaging Med Surg
Shen D, Xie X, Zheng X, Wang X, Wang Q, Yang L, Liang Y, Li C, Yang A, Xue J.   +9 more
europepmc   +1 more source

Contrast-enhanced CT as a non-invasive alternative for lung shunt fraction estimation in hepatic transarterial radioembolization. [PDF]

Radiol Adv
Mehadji B, Marx T, Carter A, Goldman RE, Vu CT, Roncali E.   +5 more
europepmc   +1 more source